Standardized management of targeted drugs for rheumatism
10.3760/cma.j.cn112138-20211220-00897
- VernacularTitle:风湿病靶向药物使用规范
- Author:
Xin WU
1
;
Wufang QI
;
Zhiqiang WANG
;
Huji XU
;
Yan ZHAO
Author Information
1. 海军军医大学第二附属医院风湿免疫科，上海 200003
- Keywords:
Rheumatism;
Targeted drugs;
Treatment
- From:
Chinese Journal of Internal Medicine
2022;61(7):756-763
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, with the continuous in-depth research on the pathogenesis of rheumatism and the rapid development of biopharmaceutical technology, the development of targeted drugs for rheumatism is in full swing. In order to better standardize the diagnosis and treatment of rheumatism and the rational application of targeted drugs, the Chinese Rheumatology Association will introduce the targeted drugs for rheumatism that have been approved by the China National Medical Products Administration so far, and provide clinicians with standardized diagnosis and treatment reference.
